IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $959,092 | +33.6% | 21,144 | +20.8% | 0.01% | -9.1% |
| Q2 2023 | $718,025 | -26.7% | 17,500 | -21.1% | 0.01% | -63.3% |
| Q3 2022 | $980,000 | +303.3% | 22,170 | +237.3% | 0.03% | +233.3% |
| Q2 2022 | $243,000 | -52.8% | 6,573 | -52.7% | 0.01% | -50.0% |
| Q1 2022 | $515,000 | -43.9% | 13,900 | -8.5% | 0.02% | +200.0% |
| Q4 2019 | $918,000 | +183.3% | 15,195 | +153.2% | 0.01% | +50.0% |
| Q4 2018 | $324,000 | -89.7% | 6,000 | -90.2% | 0.00% | -81.0% |
| Q3 2018 | $3,146,000 | +5.3% | 61,000 | -14.9% | 0.02% | +40.0% |
| Q2 2018 | $2,989,000 | +45.2% | 71,713 | +53.6% | 0.02% | +36.4% |
| Q1 2018 | $2,058,000 | +710.2% | 46,694 | +825.6% | 0.01% | +57.1% |
| Q4 2017 | $254,000 | -56.8% | 5,045 | -56.3% | 0.01% | -93.8% |
| Q2 2017 | $588,000 | – | 11,550 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |